tiprankstipranks
PharmaSGP Holding SE (DE:PSG)
XETRA:PSG
Germany Market

PharmaSGP Holding SE (PSG) Income Statement

Compare
4 Followers

PharmaSGP Holding SE Income Statement

Last quarter (Q3 2022), PharmaSGP Holding SE's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, PharmaSGP Holding SE's net income was $3.95M. See PharmaSGP Holding SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ 58.86M$ 57.04M$ 56.71M
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ 3.57M$ 486.00K$ 397.00K
EBITDA
$ 18.42M$ 14.71M$ 22.73M
Operating Income
$ 15.49M$ 16.07M$ 24.48M
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ 10.69M$ 10.64M$ 16.71M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

PharmaSGP Holding SE Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis